SIREN : 794436360
SILVER MED is a French company founded 12 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in ALES (30100), this company of category PME shows in 2024 a net income positive of 155 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 155 154 € | 296 274 € | 40 094 € | 51 368 € | 27 906 € | 67 092 € | 26 105 € | -2 271 € | 487 € |
| EBITDA | -5 144 € | -1 642 € | -1 393 € | -1 033 € | -928 € | -929 € | -1 078 € | -2 271 € | -832 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, SILVER MED generates positive net income of 155 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 487 € -> 155 k€.
-5 144 €
-5 144 €
155 154 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.0%
100.0%
0.0
In 2024, the debt ratio of SILVER MED (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of SILVER MED (100.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of SILVER MED (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 435 776€ to 3 006 666€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SILVER MED with other companies in the same sector:
Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires
The revenue of SILVER MED is not publicly disclosed (confidential accounts filed with INPI).
Yes, SILVER MED generated a net profit of 155 k€ in 2024.
The headquarters of SILVER MED is located in ALES (30100), in the department Gard.
The tax return of SILVER MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SILVER MED operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.